top of page

🧠💊 Dispatch: Ketamine, Control & The Cost of Escape Fact Check Report – July 2025

  • Writer: IGGY DWARF | Toronto, ON
    IGGY DWARF | Toronto, ON
  • Jul 27
  • 2 min read

Updated: Jul 27

🧠💊 Dispatch: Ketamine, Control & The Cost of Escape

Fact Check Report – July 2025

"When healing tools wear a mask of control—ketamine's journey from battlefield trauma to political theatre echoes through the shadows of privilege.”
"When healing tools wear a mask of control—ketamine's journey from battlefield trauma to political theatre echoes through the shadows of privilege.”

While ketamine continues its meteoric rise from club scene dissociation to FDA-sanctioned mental health remedy, its dual identity as both medicine and mechanism of control remains under-scrutinized. Recent developments invite speculation not just about its uses—but who benefits from its deployment, and who remains vulnerable.

🔬 Claim: Patents for date rape drug detection have been purchased by private investors to control pricing.

  • Finding: While specific examples exist of patented detection tech—such as chemical-coated straws and smartphone-integrated sensors—there is no public record of patents being bought with the intent to price out street use. However, pricing and accessibility often do reflect the investor’s priorities.

  • Assessment: Unconfirmed but plausible. Fits historical patterns of privatizing safety and limiting access to marginalized groups.

⚔️ Claim: Ketamine was pushed into White House policy circles under Trump to address PTSD and veteran suicide.

  • Finding: In 2019, Trump expedited the rollout of esketamine, a derivative of ketamine, through the VA system. He reportedly characterized it inaccurately as a stimulant and dismissed advisory board objections.

  • Assessment: Confirmed. Trump's involvement is documented, albeit controversial. The drug’s high cost ($737/dose) also challenges its accessibility.

🕳️ Claim: Trump’s past relationship with Epstein influences drug policy narratives and raises ethical concerns.

  • Finding: WSJ published a 2003 birthday letter from Trump to Epstein, containing crude imagery and suggestive remarks. Trump denied authorship and is now suing the Journal’s parent company for $10 billion.

  • Assessment: Confirmed. The letter exists. The lawsuit and subsequent efforts to seal/unseal Epstein records suggest ongoing political tension.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page